The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data
- PMID: 24302511
- PMCID: PMC3855491
- DOI: 10.1136/bmjopen-2013-004074
The role of private care in the interval between diagnosis and treatment of breast cancer in Northern Ireland: an analysis of Registry data
Abstract
Objective: To examine the differences in the interval between diagnosis and initiation of treatment among women with breast cancer in Northern Ireland.
Design: A cross-sectional observational study.
Setting: All breast cancer care patients in the Northern Ireland Cancer Registry in 2006.
Participants: All women diagnosed and treated for breast cancer in Northern Ireland in 2006.
Main outcome measure: The number of days between diagnosis and initiation of treatment for breast cancer.
Results: The mean (median) interval between diagnosis and initiation of treatment among public patients was 19 (15) compared with 14 (12) among those whose care involved private providers. The differences between individual public providers were as marked as those between the public and private sector-the mean (median) ranging between 14 (12) and 25 (22) days. Multivariate models revealed that the differences were evident when a range of patient characteristics were controlled for including cancer stage.
Conclusions: A relatively small number of women received care privately in Northern Ireland but experienced shorter intervals between diagnosis and initiation of treatment than those who received care wholly in the public system. The variation among public providers was as great as that between the public and private providers. The impact of such differences on survival and in light of waiting time targets introduced in Northern Ireland warrants investigation.
Keywords: HEALTH ECONOMICS; HEALTH SERVICES ADMINISTRATION & MANAGEMENT.
Figures
Similar articles
-
Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?PLoS One. 2016 Apr 7;11(4):e0153206. doi: 10.1371/journal.pone.0153206. eCollection 2016. PLoS One. 2016. PMID: 27054698 Free PMC article.
-
Breast cancer outcomes in a private hospital appear better than national outcomes in a country with a mixed public/private healthcare model.Ir J Med Sci. 2023 Apr;192(2):527-531. doi: 10.1007/s11845-022-03003-z. Epub 2022 Apr 12. Ir J Med Sci. 2023. PMID: 35415773
-
The NCI All Ireland Cancer Conference.Oncologist. 1999;4(4):275-277. Oncologist. 1999. PMID: 10545862
-
The access randomized clinical trial of public versus private physiotherapy for low back pain.Spine (Phila Pa 1976). 2012 Jan 15;37(2):85-96. doi: 10.1097/BRS.0b013e3182127457. Spine (Phila Pa 1976). 2012. PMID: 21289590 Clinical Trial.
-
From symptom discovery to treatment - women's pathways to breast cancer care: a cross-sectional study.BMC Cancer. 2018 Mar 21;18(1):312. doi: 10.1186/s12885-018-4219-7. BMC Cancer. 2018. PMID: 29562894 Free PMC article. Review.
Cited by
-
Exploring patient experiences of cancer care in Northern Ireland: A thematic analysis of free-text responses to the 2018 Northern Ireland Patient Experience Survey (NICPES).BMC Health Serv Res. 2021 Jun 7;21(1):564. doi: 10.1186/s12913-021-06577-z. BMC Health Serv Res. 2021. PMID: 34098944 Free PMC article.
-
Differences in Breast Cancer Survival between Public and Private Care in New Zealand: Which Factors Contribute?PLoS One. 2016 Apr 7;11(4):e0153206. doi: 10.1371/journal.pone.0153206. eCollection 2016. PLoS One. 2016. PMID: 27054698 Free PMC article.
-
Survival of cancer patients with pre-existing heart disease.BMC Cancer. 2022 Aug 3;22(1):847. doi: 10.1186/s12885-022-09944-z. BMC Cancer. 2022. PMID: 35922767 Free PMC article.
-
Challenges to the early diagnosis and treatment of breast cancer in developing countries.World J Clin Oncol. 2014 Aug 10;5(3):465-77. doi: 10.5306/wjco.v5.i3.465. World J Clin Oncol. 2014. PMID: 25114860 Free PMC article. Review.
References
-
- Cancer Research UK Breast Cancer Incidence Statistics, 2013
-
- Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011;19:CD001877. - PubMed
-
- Will BP, Berthelot JM, Le Petit C, et al. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000;36:724–35 - PubMed
-
- Groot MT, Baltussen R, Uyl-de Groot CA, et al. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J 2006; 12(Suppl 1):S81–90 - PubMed
-
- Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995;87:417–26 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources